First Atom Therapeutics
PrivateLast Round
Grant
May 20, 2025
Total Funding Raised
$1.38M
Company Overview
First Atom Therapeutics operates in Healthcare & Life Sciences and is based in Tampa, Florida. Its latest recorded funding round was a Grant round in May 2025.
First Atom Therapeutics is a biotechnology company that uses an AI-integrated, zero-shot de novo drug design platform to develop novel therapeutics for neurodegenerative, neuro-oncological, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
First Atom Therapeutics Comparables
Compare First Atom Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TandemAI | 80% | |
| Aqemia | 77% | |
| Tay Therapeutics | 77% |
For institutional investors. Book with your work email.
First Atom Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 20, 2025 | ||||
| Grant | Nov 13, 2024 | ||||
| Accelerator | Sep 22, 2023 | ||||
| Seed | Jul 25, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
First Atom Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| Tampa Bay Technology Incubator | Seed |
| Johnson & Johnson Innovation - JLABS | Accelerator |
| CMT Research Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2025
Received grant from CMT Research Foundation.
- Jul 25, 2022
$1.38M raised from Tampa Bay Technology Incubator.
For institutional investors. Book with your work email.
First Atom Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about First Atom Therapeutics's valuation, stock price, and market status.
Is First Atom Therapeutics a public or private company?
First Atom Therapeutics is a private company.
What is the current stock price of First Atom Therapeutics?
First Atom Therapeutics is a private company, so its shares have no public market price. Caplight tracks First Atom Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is First Atom Therapeutics worth (valuation)?
Valuation information for First Atom Therapeutics is not publicly available.
Can I buy First Atom Therapeutics stock?
First Atom Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was First Atom Therapeutics's last funding round?
First Atom Therapeutics's most recent funding round was Grant on May 20, 2025.
Who are the main investors in First Atom Therapeutics?
Key investors in First Atom Therapeutics include The ALS Association, Public Health Emergency Medical Countermeasures Enterprise, Tampa Bay Technology Incubator, Johnson & Johnson Innovation - JLABS, CMT Research Foundation.
Will First Atom Therapeutics IPO soon?
No public IPO plans have been announced for First Atom Therapeutics.
How can I track First Atom Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in First Atom Therapeutics's shares on secondary markets.